Nu Skin Enterprises Inc. (NUS)
Nu Skin Enterprises Statistics
Share Statistics
Nu Skin Enterprises has 49.72M shares outstanding. The number of shares has increased by 0.11% in one year.
Shares Outstanding | 49.72M |
Shares Change (YoY) | 0.11% |
Shares Change (QoQ) | 0.02% |
Owned by Institutions (%) | 75.7% |
Shares Floating | 47.56M |
Failed to Deliver (FTD) Shares | 8.24K |
FTD / Avg. Volume | 1.15% |
Short Selling Information
The latest short interest is 2.32M, so 4.7% of the outstanding shares have been sold short.
Short Interest | 2.32M |
Short % of Shares Out | 4.7% |
Short % of Float | 4.76% |
Short Ratio (days to cover) | 3.32 |
Valuation Ratios
The PE ratio is -2.33 and the forward PE ratio is 7.31. Nu Skin Enterprises's PEG ratio is 0.
PE Ratio | -2.33 |
Forward PE | 7.31 |
PS Ratio | 0.2 |
Forward PS | 0.2 |
PB Ratio | 0.53 |
P/FCF Ratio | 4.88 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Nu Skin Enterprises.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.82 |
Quick Ratio | 1.17 |
Debt / Equity | 0.69 |
Debt / EBITDA | -2.98 |
Debt / FCF | 6.44 |
Interest Coverage | -5.74 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $558.74K |
Profits Per Employee | $-47.29K |
Employee Count | 3,100 |
Asset Turnover | 1.18 |
Inventory Turnover | 2.89 |
Taxes
Income Tax | -28.46M |
Effective Tax Rate | 16.26% |
Stock Price Statistics
The stock price has increased by -57.88% in the last 52 weeks. The beta is 1.09, so Nu Skin Enterprises's price volatility has been higher than the market average.
Beta | 1.09 |
52-Week Price Change | -57.88% |
50-Day Moving Average | 7.21 |
200-Day Moving Average | 7.73 |
Relative Strength Index (RSI) | 29.05 |
Average Volume (20 Days) | 717.01K |
Income Statement
In the last 12 months, Nu Skin Enterprises had revenue of 1.73B and earned -146.59M in profits. Earnings per share was -2.95.
Revenue | 1.73B |
Gross Profit | 1.18B |
Operating Income | -151.59M |
Net Income | -146.59M |
EBITDA | -151.59M |
EBIT | -148.64M |
Earnings Per Share (EPS) | -2.95 |
Balance Sheet
The company has 186.88M in cash and 452.05M in debt, giving a net cash position of -265.17M.
Cash & Cash Equivalents | 186.88M |
Total Debt | 452.05M |
Net Cash | -265.17M |
Retained Earnings | 1.71B |
Total Assets | 1.47B |
Working Capital | 241.99M |
Cash Flow
In the last 12 months, operating cash flow was 111.74M and capital expenditures -41.58M, giving a free cash flow of 70.16M.
Operating Cash Flow | 111.74M |
Capital Expenditures | -41.58M |
Free Cash Flow | 70.16M |
FCF Per Share | 1.41 |
Margins
Gross margin is 68.23%, with operating and profit margins of -8.75% and -8.46%.
Gross Margin | 68.23% |
Operating Margin | -8.75% |
Pretax Margin | -10.11% |
Profit Margin | -8.46% |
EBITDA Margin | -8.75% |
EBIT Margin | -8.75% |
FCF Margin | 4.05% |
Dividends & Yields
NUS pays an annual dividend of $0.3, which amounts to a dividend yield of 3.14%.
Dividend Per Share | $0.30 |
Dividend Yield | 3.14% |
Dividend Growth (YoY) | 0% |
Payout Ratio | -10.17% |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for NUS is $6.88, which is 25.5% higher than the current price. The consensus rating is "Hold".
Price Target | $6.88 |
Price Target Difference | 25.5% |
Analyst Consensus | Hold |
Analyst Count | 2 |
Scores
Altman Z-Score | 2.92 |
Piotroski F-Score | 4 |